Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2138]

Neuronal molecule makes prostate cancer more aggressive

Neuronal molecule makes prostate cancer more aggressive

National prostate cancer trial testing therapy based on molecular discovery

National prostate cancer trial testing therapy based on molecular discovery

MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localised prostate cancer

MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localised...

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

Experts explain treatment options for a common cancer complication

Experts explain treatment options for a common cancer complication

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non...

Exercise is medicine for cancer and every dose counts - even in late stages in the disease

Exercise is medicine for cancer and every dose counts - even in late stages in the disease

New prostate cancer diagnostic pathway paves way for general screening

New prostate cancer diagnostic pathway paves way for general screening

Hospital parking fees contribute to financial toxicity for cancer patients

Hospital parking fees contribute to financial toxicity for cancer patients

Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS England early access deal for the treatment of patients with mHSPC

Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS...

More from ecancer